Physician profile
Michael Eugene Mckinney
NPI 1295724771
$8,416.68
in general payments reported to CMS, 2019-2025
29 companies · $3,406 in 2025
The $3,406 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $155 · 2021: $240 · 2022: $756 · 2023: $2,468 · 2024: $1,278 · 2025: $3,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,494 · Food and Beverage: $2,590 · Education: $67.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,493.78 |
| Food and Beverage | $2,590.17 |
| Education | $67.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,742.46 | 2019-2025 | Aveir, Tendril, Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $510.37 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $377.62 | 2019-2025 | |
| Pfizer INC. | $256.93 | 2021-2025 | |
| Shockwave Medical, INC | $203.12 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Intuitive Surgical, INC. | $197.40 | 2025 | |
| Merck Sharp & Dohme LLC | $135.94 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $114.48 | 2021-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $102.38 | 2022-2024 | Xarelto |
| Inspire Medical Systems, INC. | $100.00 | 2025 | Inspire |
| Boston Scientific Corporation | $96.06 | 2020-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Phathom Pharmaceuticals, INC. | $81.95 | 2025 | Voquezna |
| Novo Nordisk INC | $63.15 | 2025 | Wegovy, Ozempic |
| Medtronic, INC. | $57.14 | 2024 | Linq II |
| Thrombolex, INC. | $52.75 | 2024-2025 | Bashir Endovascular Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $44.75 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.44 | 2022 | |
| Angiodynamics, INC. | $35.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.03 | 2025 | |
| Terumo Medical Corporation | $24.44 | 2024 | Progreat, Azur Cx Detachable |
| Edwards Lifesciences Corporation | $23.10 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.22 | 2025 | Elaprase |
| Cook Medical LLC | $18.93 | 2022 | |
| Amgen INC. | $16.67 | 2023 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $15.28 | 2023 | Arcalyst |
| Philips North America LLC | $14.70 | 2023 | |
| Cardinal Health 200 LLC | $12.66 | 2020 | |
| Bardy Diagnostics, INC. | $12.24 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mckinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.